Contract 75A50324F80015
Fresenius Kabi USA, Llc · Department Of Health And Human Services · September 30, 2024
Fresenius Kabi USA, Llc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 30, 2024 for $5.42 million of work in pharmaceutical preparation manufacturing. Performance is in Lake Zurich, IL. This is a task or delivery order issued under parent IDIQ V797D70253. It uses firm fixed-price contract pricing.
Contract details
- PIID
- 75A50324F80015
- Parent IDIQ
- V797D70253
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Lake Zurich, IL
- First action
- September 30, 2024
Description
THE PURPOSE OF THIS DELIVERY ORDER IS TO PROCURE AND REPLENISH PRODUCT FOR THE CHEMPAK AND PPG TEAM
Modification timeline
-
September 30, 2024Base award$5.42M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 27, 2026 | $92.33M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50324F80015?
Contract 75A50324F80015 is a federal contract awarded to Fresenius Kabi USA, Llc by Department Of Health And Human Services on September 30, 2024 for $5.42 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75A50324F80015?
Fresenius Kabi USA, Llc won contract 75A50324F80015 from Department Of Health And Human Services.
How much is contract 75A50324F80015 worth?
Contract 75A50324F80015 has obligated $5.42 million to date.